Capstar Special Purpose (CPSR) Adds Backstop to Gelesis Deal

Capstar Special Purpose (CPSR) Adds Backstop to Gelesis Deal

Capstar (NYSE:CPSR) announced in an 8-K this morning that it is has added a $15 million backstop to its combination with biotech firm Gelesis to secure the deal’s cash terms ahead of its shareholder vote. The backstop combines with the transaction’s existing $90 million PIPE to meet the deal’s $105 million minimum cash condition on
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.